Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,121.58
    +7.23 (+0.34%)
     
  • Crude Oil

    83.02
    +1.67 (+2.05%)
     
  • Gold

    2,241.30
    +28.60 (+1.29%)
     
  • Silver

    25.00
    +0.24 (+0.98%)
     
  • EUR/USD

    1.0790
    -0.0040 (-0.37%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2621
    -0.0017 (-0.14%)
     
  • USD/JPY

    151.3860
    +0.1400 (+0.09%)
     
  • Bitcoin USD

    70,852.96
    +2,115.47 (+3.08%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

FEMSA's (FMX) Unit Acquires AGV, Expands Footprint in Brazil

Fomento Economico Mexicano, S.A.B. de C.V. FMX, alias FEMSA’s logistics subsidiary — Solistica — completed its previously announced deal to acquire AGV, which is a leader in value-added warehousing and distribution platform in Brazil. AGV has gross annual sales of nearly R$650 million.

The deal, signed in November 2019, is an important step for Solistica’s Brazilian strategy, where it expects to turn into the first fully integrated Third Party Logistics (“3PL”) solution provider. This will help Solistica stand out from other key players in the market. It is already the leading provider of the Less than Truckload (“LTL”) logistics service in Brazil through acquisitions like Expresso Jundiai and Atlas.

Last week, the FEMSA Comercio unit was notified by FEMSA’s minority partner – Grupo Socofar (“Socofar”) – of its intention to exercise its put right to sell the remaining 40% interest in Socofar. Following the transaction, FEMSA, through its subsidiary, will be the sole shareholder of Socofar.

The terms of the put option determine the valuation of Socofar through a fair market procedure by a panel of independent investment bankers. The final price for the 40% stake will be local currency adjustments, upon the closing of the transaction. The company expects to close the transaction in January 2020.

Over the years, FEMSA has been taking prudent steps to diversify the product portfolio, while expanding in the small-box retail segment. In sync, the company recently formed a 50-50 JV with Raízen Conveniencias in Brazil, and acquired minority stake and agreed to form a JV with Jetro Restaurant Depot (“JRD”). The Raízen JV marks FEMSA Comercio’s entry in Brazil’s convenience sector as a developer and operator of small-format proximity and convenience stores. The transaction focuses on increasing penetration of Raízen’s Select convenience stores at its service stations and developing value propositions for the OXXO brand’s stand-alone proximity outlets.

Meanwhile, FEMSA entered the wholesale cash and carry business in the United States, with the minority stakes in JRD. Further, the proposed JV provides the necessary background to bring the cash and carry business platform to Mexico and other Latin America markets in the long run.

These transactions reflect the company’s focus on strengthening position in Brazil, Mexico and other Latin America markets.

Apart from these, the Zacks Rank #4 (Sell) company is expanding drugstore operations as it sees significant potential in the space. Additionally, FEMSA is on track to build infrastructure and integrate its four legacy drugstore operations into a single operating platform.

Notably, shares of the company have gained 5.3% in the past three months compared with the industry’s 2.2% growth.

 



3 Better-Ranked Picks From the Beverage Industry

The Boston Beer Company, Inc SAM, with a Zacks Rank #2 (Buy), has an impressive long-term earnings growth rate of 10%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Coca-Cola European Partners PLC CCEP currently has a long-term earnings growth rate of 8.9% and a Zacks Rank #2.

Luckin Coffee Inc LK, also a Zacks Rank #2 stock, has delivered a positive earnings surprise of 2.21% in the trailing four quarters, on average.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Boston Beer Company, Inc. (SAM) : Free Stock Analysis Report
 
Fomento Economico Mexicano S.A.B. de C.V. (FMX) : Free Stock Analysis Report
 
Coca-Cola European Partners PLC (CCEP) : Free Stock Analysis Report
 
Luckin Coffee Inc. Sponsored ADR (LK) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement